Associate Director Clinical Pharmacology Modeling & Simulation
GSK
Summary
We have an exciting opportunity at GSK for a hands-on Quantitative Clinical Pharmacologist with a strong pharmacometrics focus to join our team supporting ViiV Healthcare (HIV) and Oncology lifecycle management programs, with possible support for infectious disease programs.
Job description
This is an individual contributor role with no formal line-management responsibility. You will act as the Clinical Pharmacology, Modeling and Simulation lead for assigned assets, with a strong emphasis on hands-on pharmacometrics alongside strategic input to development teams. You will work on both small molecules and biologics, across HIV and Oncology programs, with opportunities to support other infectious disease assets.
Key Responsibilities
- Act as the Clinical Pharmacology, Modeling and Simulation representative on cross-functional medical development teams for assigned HIV and Oncology assets, contributing to development strategy.
- Lead hands-on population PK, PK/PD and exposure-response analyses, from analysis planning and dataset specification through model development, evaluation and reporting.
- Apply clinical pharmacokinetic, pharmacodynamic and modeling & simulation principles to support efficient clinical development, risk management, registration and lifecycle management.
- Contribute to the design of efficient clinical development programs and registration packages, and support lifecycle management of infectious disease and Oncology assets.
- Play a central role in selecting and justifying doses and dosing regimens, including characterizing exposure-response relationships and recommendations for relevant patient populations.
- Conduct simulations to inform clinical trial design and development decisions, and conduct meta-analyses where appropriate to make use of existing data.
- Present clinical pharmacology strategy and model-based evidence to governance boards, development teams and regulatory agencies.
- Apply relevant regulatory guidance to clinical pharmacology plans, study designs, analyses and development strategies.
- Design and interpret clinical pharmacology studies evaluating intrinsic and extrinsic factors affecting pharmacokinetics and pharmacodynamics.
- Identify appropriate opportunities to apply PBPK and other in silico approaches to evaluate drug interactions and special populations.
- Author and contribute to clinical development and regulatory documents, including protocols, reports, investigator brochures, briefing books, clinical pharmacology summaries and submission packages.
- Contribute clinical pharmacology evidence throughout regulatory interactions, from development-stage meetings through registration and product labeling.
- Advance model-informed drug development through high-quality scientific collaboration, external engagement, publication and conference presentation where appropriate.
- Learn and apply emerging modeling and simulation methods to improve program efficiency and the quality of investment and development decisions.
- Collaborate effectively with clinicians, statisticians, programmers, biologists, regulatory colleagues, drug metabolism scientists and other matrix partners.
- Stay hands-on with quantitative analyses while giving clear scientific recommendations to development teams and stakeholders.
Basic Qualifications & Skills
- Advanced degree in a relevant life science discipline, such as a PhD, PharmD or MD, supporting a successful career in quantitative clinical pharmacology within pharmaceutical research and development.
- 3+ years of experience in clinical pharmacokinetics, pharmacometrics and model-informed drug development in the pharmaceutical industry or equivalent, including the design, analysis and reporting of clinical studies.
- One or more years of experience developing and applying population PK, PK/PD or exposure-response models to clinical development questions.
- One or more years of experience with common quantitative clinical pharmacology tools, including NONMEM or Monolix and R.
- Experience using quantitative evidence to inform dose selection and clinical development plans.
- Experience contributing to regulatory submission documents or regulatory interactions, and applying relevant FDA and ICH guidance to clinical development plans and studies.
Preferred Qualifications & Skills
- Pharmacometrics experience in HIV, Oncology or other infectious disease programs.
- Knowledge of, or the ability to quickly learn, the mechanisms, endpoints, progression and treatment of diseases within HIV, Oncology and other relevant therapy areas.
- Experience supporting late-stage clinical development, registration, lifecycle management, regulatory briefing books, dossiers or clinical pharmacology product labeling.
- Additional experience with Python, WinNonlin, Simcyp, SAS, MATLAB, or translational PK/PD approaches.
- Ability to communicate complex quantitative evidence clearly and succinctly, build effective collaborations and take personal accountability for delivery.
- Curiosity about emerging methods and technology, including high-performance computing and AI-enabled tools, with a willingness to learn and apply new approaches.
Requirements
- Advanced degree in a relevant life science discipline, such as a PhD, PharmD or MD
- 3+ years of experience in clinical pharmacokinetics, pharmacometrics and model-informed drug development in the pharmaceutical industry or equivalent
- One or more years of experience developing and applying population PK, PK/PD or exposure-response models to clinical development questions
- One or more years of experience with common quantitative clinical pharmacology tools, including NONMEM or Monolix and R
- Experience using quantitative evidence to inform dose selection and clinical development plans
- Experience contributing to regulatory submission documents or regulatory interactions, and applying relevant FDA and ICH guidance to clinical development plans and studies
Benefits
- Competitive salary
- Annual bonus
- Healthcare programs
- Wellbeing programs
- Pension plan membership
- Shares and savings program
- Hybrid working model
Company overview
GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.